Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Design and implementation of a prototype head and neck phantom for the performance evaluation of gamma imaging systems.

Alqahtani MS, Lees JE, Bugby SL, Samara-Ratna P, Ng AH, Perkins AC.

EJNMMI Phys. 2017 Dec;4(1):19. doi: 10.1186/s40658-017-0186-3. Epub 2017 Jul 6.

2.

General practitioner management related to skin cancer prevention and screening during standard medical encounters: a French cross-sectional study based on the International Classification of Primary Care.

Rat C, Houd S, Gaultier A, Grimault C, Quereux G, Mercier A, Letrilliart L, Dreno B, Nguyen JM.

BMJ Open. 2017 Jan 30;7(1):e013033. doi: 10.1136/bmjopen-2016-013033.

3.
4.

Correlates of Sun Protection and Sunburn in Children of Melanoma Survivors.

Tripp MK, Peterson SK, Prokhorov AV, Shete SS, Lee JE, Gershenwald JE, Gritz ER.

Am J Prev Med. 2016 Sep;51(3):e77-85. doi: 10.1016/j.amepre.2016.02.032. Epub 2016 Apr 7.

PMID:
27067306
5.

Dermal melanoma: A report on prognosis, outcomes, and the utility of sentinel lymph node biopsy.

Doepker MP, Thompson ZJ, Harb JN, Messina JL, Puleo CA, Egan KM, Sarnaik AA, Gonzalez RJ, Sondak VK, Zager JS.

J Surg Oncol. 2016 Jan;113(1):98-102. doi: 10.1002/jso.24088. Epub 2015 Dec 10.

6.

Serum lactate dehydrogenase and survival following cancer diagnosis.

Wulaningsih W, Holmberg L, Garmo H, Malmstrom H, Lambe M, Hammar N, Walldius G, Jungner I, Ng T, Van Hemelrijck M.

Br J Cancer. 2015 Nov 3;113(9):1389-96. doi: 10.1038/bjc.2015.361. Epub 2015 Oct 15.

7.

Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis.

Contador-Troca M, Alvarez-Barrientos A, Merino JM, Morales-Hernández A, Rodríguez MI, Rey-Barroso J, Barrasa E, Cerezo-Guisado MI, Catalina-Fernández I, Sáenz-Santamaría J, Oliver FJ, Fernandez-Salguero PM.

Mol Cancer. 2015 Aug 5;14:148. doi: 10.1186/s12943-015-0419-9.

8.

Triggering Receptor Expressed on Myeloid Cells in Cutaneous Melanoma.

Nguyen AH, Koenck C, Quirk SK, Lim VM, Mitkov MV, Trowbridge RM, Hunter WJ 3rd, Agrawal DK.

Clin Transl Sci. 2015 Oct;8(5):441-4. doi: 10.1111/cts.12308. Epub 2015 Jul 16.

9.

Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting.

Lipson EJ, Sharfman WH, Chen S, McMiller TL, Pritchard TS, Salas JT, Sartorius-Mergenthaler S, Freed I, Ravi S, Wang H, Luber B, Sproul JD, Taube JM, Pardoll DM, Topalian SL.

J Transl Med. 2015 Jul 5;13:214. doi: 10.1186/s12967-015-0572-3.

10.

The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.

Jenkins MH, Croteau W, Mullins DW, Brinckerhoff CE.

Matrix Biol. 2015 Oct;48:66-77. doi: 10.1016/j.matbio.2015.05.007. Epub 2015 May 16.

11.

Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice.

Rossi AH, Farias A, Fernández JE, Bonomi HR, Goldbaum FA, Berguer PM.

PLoS One. 2015 May 14;10(5):e0126827. doi: 10.1371/journal.pone.0126827. eCollection 2015.

12.

Vitamin D deficiency at melanoma diagnosis is associated with higher Breslow thickness.

Wyatt C, Lucas RM, Hurst C, Kimlin MG.

PLoS One. 2015 May 13;10(5):e0126394. doi: 10.1371/journal.pone.0126394. eCollection 2015.

13.

CXCR3 signaling in BRAFWT melanoma increases IL-8 expression and tumorigenicity.

Jenkins MH, Brinckerhoff CE, Mullins DW.

PLoS One. 2015 Mar 23;10(3):e0121140. doi: 10.1371/journal.pone.0121140. eCollection 2015.

14.

Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma.

Wu SY, Huang SP, Lo YC, Liu RS, Wang SJ, Lin WJ, Shen CC, Wang HE.

Biomed Res Int. 2014;2014:912498. doi: 10.1155/2014/912498. Epub 2014 Sep 1.

15.

Sentinel lymph node biopsy in head and neck melanoma*.

Giudice G, Leuzzi S, Robusto F, Ronghi V, Nacchiero E, Giardinelli G, Di Gioia G, Ragusa L, Pascone M.

G Chir. 2014 May-Jun;35(5-6):149-55.

16.

Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance.

Azimi A, Pernemalm M, Frostvik Stolt M, Hansson J, Lehtiö J, Egyházi Brage S, Hertzman Johansson C.

Br J Cancer. 2014 May 13;110(10):2489-95. doi: 10.1038/bjc.2014.169. Epub 2014 Apr 10.

17.

Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma.

Iyer JG, Storer BE, Paulson KG, Lemos B, Phillips JL, Bichakjian CK, Zeitouni N, Gershenwald JE, Sondak V, Otley CC, Yu SS, Johnson TM, Liegeois NJ, Byrd D, Sober A, Nghiem P.

J Am Acad Dermatol. 2014 Apr;70(4):637-43. doi: 10.1016/j.jaad.2013.11.031. Epub 2014 Feb 9.

18.

Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032.

Jenkins MH, Steinberg SM, Alexander MP, Fisher JL, Ernstoff MS, Turk MJ, Mullins DW, Brinckerhoff CE.

Pigment Cell Melanoma Res. 2014 May;27(3):495-501. doi: 10.1111/pcmr.12220. Epub 2014 Mar 6. No abstract available.

19.

Targeted melanoma prevention intervention: a cluster randomized controlled trial.

Rat C, Quereux G, Riviere C, Clouet S, Senand R, Volteau C, Dreno B, Nguyen JM.

Ann Fam Med. 2014 Jan-Feb;12(1):21-8. doi: 10.1370/afm.1600.

20.

Treatment outcomes of advanced stage malignant melanoma in hand and foot after amputation in Korean patients.

Cho K, Jung ST.

Clin Orthop Surg. 2013 Dec;5(4):314-20. doi: 10.4055/cios.2013.5.4.314. Epub 2013 Nov 18.

Supplemental Content

Support Center